ThinkEquity Initiates Coverage on Clarient (CLRT) with a Buy
CLRT Hot Sheet
Rating Summary:0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
ThinkEquity initiates coverage on Clarient (Nasdaq: CLRT) with a Buy.
To see all the upgrades/downgrades on shares of CLRT, visit our Analyst Ratings page.
Clarient, Inc. (Clarient) is an oncology diagnostics services company.
To see all the upgrades/downgrades on shares of CLRT, visit our Analyst Ratings page.
Clarient, Inc. (Clarient) is an oncology diagnostics services company.
You May Also Be Interested In
- UPDATE: Capstone Starts Facebook (FB) at Hold as Premium Multiple Not Justified
- UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
- Wunderlich Securities Starts Fastenal (FAST) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
